Healthcare / Healthcare PlansTaipei Exchange
$19.60
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 24%
FCF escenarios
weak_data · normalized FCF $43.1M · quality 68.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
30/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$889M
P/E
103.2x
↑EV/EBITDA
12.3x
↑ROE
0.9%
↑Gross Margin
18.0%
↓Debt/Equity
0.30
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-9.9%
FCF CAGR
-23.6%
FCF margin
3.8%
FCF / Net income
5.14x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.13B · net income $8.4M · FCF $43.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.13B | $1.13B | $1.25B | $1.26B | $1.55B |
| Net Income | $8.4M | $8.4M | $19.2M | $2.4M | $25.4M |
| EBITDA | $70.8M | $70.8M | $90.3M | $86.4M | $138.5M |
| EPS | — | — | 0.42 | 0.05 | 0.56 |
| Gross Margin | 18.0% | 18.0% | 19.1% | 19.5% | 20.2% |
| Operating Margin | 0.3% | 0.3% | 1.0% | 0.2% | 3.9% |
| Net Margin | 0.7% | 0.7% | 1.5% | 0.2% | 1.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.30 | 0.30 | 0.32 | 0.40 | 0.37 |
| Current Ratio | 1.76 | 1.76 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $43.1M | $43.1M | $-3.2M | $48.1M | $96.8M |
| Returns | |||||
| ROE | 0.9% | 0.9% | 2.0% | 0.3% | 2.7% |
| Valuation | |||||
| P/E | 103.16 | 103.16 | 49.52 | 579.00 | 62.23 |
| EV/EBITDA | 12.28 | 12.28 | 9.87 | 11.90 | 8.39 |
| P/B | 0.96 | 0.96 | 1.00 | 1.43 | 1.68 |
| Growth & Yield | |||||
| Revenue Growth | -9.8% | -9.8% | -0.2% | -18.7% | — |
| EPS Growth | — | — | 740.0% | -91.1% | — |
| Dividend Yield | 2.9% | 2.9% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-11.5%
Start / end P/E
n/dx → n/dx
EPS bridge
0.42 → n/d
Residual
-14.4%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.